Detailed information for compound 942211

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 306.83 | Formula: C17H23ClN2O
  • H donors: 2 H acceptors: 1 LogP: 4.91 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(Nc1cccc(c1)Cl)NC/C=C(\CCC=C(C)C)/C
  • InChi: 1S/C17H23ClN2O/c1-13(2)6-4-7-14(3)10-11-19-17(21)20-16-9-5-8-15(18)12-16/h5-6,8-10,12H,4,7,11H2,1-3H3,(H2,19,20,21)/b14-10-
  • InChiKey: LNQRODZZUIGSIQ-UVTDQMKNSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Transient receptor potential cation channel subfamily M member 8 Starlite/ChEMBL References
Homo sapiens transient receptor potential cation channel, subfamily V, member 1 Starlite/ChEMBL References
Rattus norvegicus Transient receptor potential cation channel subfamily A member 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis transient receptor potential cation channel Get druggable targets OG5_132409 All targets in OG5_132409
Schistosoma mansoni transient receptor potential cation channel subfamily A member Get druggable targets OG5_132409 All targets in OG5_132409
Schistosoma japonicum Transient receptor potential cation channel subfamily A member 1, putative Get druggable targets OG5_132409 All targets in OG5_132409
Schistosoma japonicum ko:K04984 transient receptor potential cation channel, subfamily A, member 1, putative Get druggable targets OG5_132409 All targets in OG5_132409
Schistosoma japonicum Transient receptor potential cation channel subfamily A member 1, putative Get druggable targets OG5_132409 All targets in OG5_132409
Echinococcus granulosus ankyrin repeat protein Get druggable targets OG5_132409 All targets in OG5_132409
Schistosoma japonicum Transient receptor potential cation channel subfamily A member 1, putative Get druggable targets OG5_132409 All targets in OG5_132409
Echinococcus granulosus transient receptor potential cation channel Get druggable targets OG5_132409 All targets in OG5_132409
Echinococcus multilocularis ankyrin repeat protein Get druggable targets OG5_132409 All targets in OG5_132409

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma mansoni transient receptor potential cation channel subfamily m member Transient receptor potential cation channel subfamily M member 8   1104 aa 1070 aa 24.6 %
Echinococcus granulosus transient receptor potential cation channel Transient receptor potential cation channel subfamily M member 8   1104 aa 1098 aa 25.1 %
Echinococcus multilocularis transient receptor potential cation channel Transient receptor potential cation channel subfamily M member 8   1104 aa 1095 aa 25.2 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Eukaryotic aspartyl protease family protein 0.0049 0.0646 1
Loa Loa (eye worm) hypothetical protein 0.0205 0.328 1
Plasmodium falciparum plasmepsin I 0.0205 0.328 1
Echinococcus multilocularis ankyrin repeat protein 0.0192 0.3057 0.9319
Brugia malayi Pepsin A precursor 0.0049 0.0646 1
Brugia malayi aspartic protease BmAsp-2, identical 0.0049 0.0646 1
Schistosoma mansoni cathepsin D (A01 family) 0.0605 1 1
Toxoplasma gondii aspartyl protease ASP1 0.0205 0.328 1
Toxoplasma gondii aspartyl proteinase (eimepsin), putative 0.0205 0.328 1
Loa Loa (eye worm) aspartyl protease 6 0.0049 0.0646 0.197
Loa Loa (eye worm) hypothetical protein 0.0049 0.0646 0.197
Plasmodium falciparum plasmepsin II 0.0205 0.328 1
Echinococcus multilocularis transient receptor potential cation channel 0.0202 0.3226 0.9835
Loa Loa (eye worm) aspartic protease BmAsp-2 0.0205 0.328 1
Plasmodium vivax aspartyl proteinase, putative 0.0205 0.328 1
Onchocerca volvulus 0.0049 0.0646 0.5
Schistosoma mansoni subfamily A1A unassigned peptidase (A01 family) 0.0205 0.328 0.2816
Brugia malayi aspartic protease BmAsp-1, identical 0.0049 0.0646 1
Loa Loa (eye worm) hypothetical protein 0.0049 0.0646 0.197
Loa Loa (eye worm) aspartic protease BmAsp-1 0.0049 0.0646 0.197
Echinococcus granulosus ankyrin repeat protein 0.0192 0.3057 0.9319
Echinococcus multilocularis cathepsin d (lysosomal aspartyl protease) 0.0205 0.328 1
Plasmodium falciparum plasmepsin VI 0.0205 0.328 1
Plasmodium falciparum plasmepsin IV 0.0205 0.328 1
Plasmodium vivax plasmepsin IV, putative 0.0205 0.328 1
Echinococcus granulosus cathepsin d lysosomal aspartyl protease 0.0205 0.328 1
Trichomonas vaginalis Clan AA, family A1, cathepsin D-like aspartic peptidase 0.0205 0.328 0.5
Brugia malayi hypothetical protein 0.0049 0.0646 1
Onchocerca volvulus 0.0049 0.0646 0.5
Echinococcus granulosus transient receptor potential cation channel 0.0202 0.3221 0.982
Brugia malayi hypothetical protein 0.0049 0.0646 1
Schistosoma mansoni transient receptor potential cation channel subfamily A member 0.0192 0.3057 0.2577

Activities

Activity type Activity value Assay description Source Reference
EC50 (binding) = 0.43 uM Agonist activity at rat TRPA1 expressed in HEK293 cells assessed as increase in intracellular Ca2+ concentration by Fluo-4-AM dye based spectrofluorimetry ChEMBL. 25455494
EC50 (binding) = 1.7 uM Agonist activity at human TRPV1 expressed in HEK293 cells assessed as increase in intracellular Ca2+ concentration by Fluo-4-AM dye based spectrofluorimetry ChEMBL. 25455494
Efficacy (binding) < 10 % Agonist activity at rat TRPM8 expressed in HEK293 cells assessed as increase in intracellular Ca2+ concentration by Fluo-4-AM dye based spectrofluorimetry relative to ionomycin ChEMBL. 25455494
Efficacy (binding) = 20.1 % Agonist activity at human TRPV1 expressed in HEK293 cells assessed as increase in intracellular Ca2+ concentration by Fluo-4-AM dye based spectrofluorimetry relative to ionomycin ChEMBL. 25455494
Efficacy (binding) = 104.3 % Agonist activity at rat TRPA1 expressed in HEK293 cells assessed as increase in intracellular Ca2+ concentration by Fluo-4-AM dye based spectrofluorimetry relative to AITC ChEMBL. 25455494
IC50 (binding) = 0.38 uM Antagonist activity against human TRPV1 expressed in HEK293 cells assessed as inhibition of capsaicin-induced increase in intracellular Ca2+ concentration by Fluo-4-AM dye based spectrofluorimetry ChEMBL. 25455494
IC50 (binding) = 0.41 uM Antagonist activity against rat TRPA1 expressed in HEK293 cells assessed as inhibition of AITC-induced increase in intracellular Ca2+ concentration by Fluo-4-AM dye based spectrofluorimetry ChEMBL. 25455494
IC50 (binding) = 0.71 uM Antagonist activity against rat TRPM8 expressed in HEK293 cells assessed as inhibition of icilin-induced increase in intracellular Ca2+ concentration by Fluo-4-AM dye based spectrofluorimetry ChEMBL. 25455494

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.